Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2000 1
2008 1
2010 1
2011 4
2013 2
2014 1
2015 1
2016 1
2018 1
2019 1
2020 2
2021 3
2022 2
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Free PMC article. Clinical Trial.
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
[Rehabilitation program for patients with low anterior resection syndrome].
Fomenko OY, Kashnikov VN, Alekseev MV, Veselov AV, Belousova SV, Aleshin DV, Morozov SV, Kozlov VA, Reutova AA, Rumiantsev AS, Nafedzov IO. Fomenko OY, et al. Among authors: kashnikov vn. Vopr Kurortol Fizioter Lech Fiz Kult. 2020;97(5):52-59. doi: 10.17116/kurort20209705152. Vopr Kurortol Fizioter Lech Fiz Kult. 2020. PMID: 33054009 Russian.
[Questionnaire of the Ryzhikh National Medical Research Centre for Coloproctology is a new tool for assessing chronic pelvic pain and pelvic organ dysfunction].
Fomenko OY, Shelygin YA, Nikityuk DB, Morozov SV, Bashankaev BN, Poryadin GV, Martynov MY, Morozov DA, Apolihina IA, Teterina TA, Dreval ON, Chagava DA, Salmasi ZM, Nikitin SS, Katunina EA, Kasyan GR, Gvozdev MY, Troshina EM, Kopachka MM, Kulikov AG, Turova EA, Romanov DV, Shkoda AS, Reutova AA, Rumiantsev AS, Fomenko ES, Popov AA, Fedorov AA, Komancev VN, Ekusheva EV, Vojtenkov VB, Nikolaev SG, Groshilin VS, Genov PG, Romih VV, Zaharchenko AV, Shornikov PV, Sinkin MV, Dilanyan OE, Isagulyan ED, Markaryan DR, Gluhov EY, Kiselev VN, Malinina OY, Marchenko VA, Silant'eva ES, Pimenova ES, Borodulina IV, Kanaev SP, Kan'shina DS, Kashnikov VN, Aleshin DV, Belousova SV, Nekrasov MA, Achkasov SI. Fomenko OY, et al. Among authors: kashnikov vn. Khirurgiia (Mosk). 2022;(12. Vyp. 2):6-25. doi: 10.17116/hirurgia20221226. Khirurgiia (Mosk). 2022. PMID: 36562669 Russian.
25 results